Shahin Sanjar
5PUBLICATIONS
4CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (5)
Sort by Publication Date:
|Apr 28, 2021
Impact of Comorbidity Prevalence and Cardiovascular Disease Status on the Efficacy and Safety of Nebulized Glycopyrrolate in Patients with COPD.Nirupama Putcha, Ayca Ozol-Godfrey, Shahin Sanjar
|Apr 21, 2021
Effect of SGRQ-Defined Chronic Bronchitis at Baseline on Treatment Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate.Donald P Tashkin, Ayca Ozol-Godfrey, Sanjay Sharma
|Apr 09, 2021
Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies.Nicola A Hanania, Abebaw M Yohannes, Ayca Ozol-Godfrey
|May 23, 2020
Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate.Jill A Ohar, Ayca Ozol-Godfrey, Thomas Goodin
|Apr 29, 2020
The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies.James F Donohue, Ayca Ozol-Godfrey, Thomas Goodin
Pageof 1
